Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Exploring the pathogenesis of AML and myelodysplastic syndromes using genome and transcriptome sequencing

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.12.19
Views: 279

Dr Ilaria Iacobucci - St. Jude Children's Research Hospital, Memphis, USA

Dr Ilaria Iacobucci speaks at the 2019 ASH meeting about the results from a study that revealed the genetic underpinnings of acute myeloid leukaemia (AML) and myelodysplastic syndromes using genome and transcriptome sequencing.

She describes the specific mutational and structural changes identified in this study which may present new targets for therapy. 

Watch our interview with Dr Charles Mullighan here.

Read more about the study here

Related videos

follow us

SIOG metastatic renal cell carcinoma

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation